Status:
COMPLETED
Promoting Transactional Supports to Optimize Social Communication Outcomes for Infants and Their Families
Lead Sponsor:
Emory University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
6-6 years
Phase:
NA
Brief Summary
This early treatment project is designed to address two significant public health challenges - the need for validated, manualized, treatments for young children with Autism Spectrum Disorder (ASD) tha...
Detailed Description
Most children with autism spectrum disorders (ASD) require special education at school age at staggering expenses to the educational system. The average annual cost for educating a child with ASD, bas...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Stage 1:
- Have an ASD sibling who is in the Emory Autism Center of Excellence.
- Inclusion Criteria for Stage 2:
- Nonresponse to Stage 1 intervention; a "nonresponder" is defined as infants who show early signs of autism and communication delay.
- Shows early signs of ASD, defined by a positive score on the Infant-Toddler Checklist (ITC) and at least two of the following autism screening tools: Early Screening for Autism and Communication Disorders (ESAC), Systematic Observation of Red Flags of ASD (SORF) Clinic, or SORF-Home.
- Exclusion Criteria:
- Parent/caregiver declines to participate.
Exclusion
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 8 2024
Estimated Enrollment :
269 Patients enrolled
Trial Details
Trial ID
NCT03307057
Start Date
February 1 2018
End Date
October 8 2024
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marcus Autism Center
Atlanta, Georgia, United States, 30329